Castor vs Clario(eCOA)

Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.

Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.

Guide updated How we compare

Compare within eCOA

Study fit, side by side

These notes describe the products in the eCOA guide.

Castor

Best for
Biotech, device and academic teams that want eCOA, eConsent and EDC in one platform with a self-service option
What to consider
Castor offers a validated instrument library with licensing handled by its services team, self-service builds that go live in weeks and a published pricing process with an entry package for early-stage companies. Its global reach and regulatory track record are smaller than the enterprise platforms'.
Read product profile

Clario

Best for
Global pivotal trials that combine eCOA with cardiac, respiratory, imaging or sensor endpoints
What to consider
Clario has the deepest enterprise eCOA profile here: studies in 120+ countries and 100+ languages, a named eCOA science team and pre-validated assessment libraries. It says it has supported 70% of FDA and EMA new drug approvals since 2015 across its endpoints. Builds are delivered by Clario and prices are not published.
Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full eCOA feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

Castor vs Clario (eCOA): category feature evidence and sources. Products are not ranked.
Category featureCastorClario
Validated instrument library and licensing
Feature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Extended support

Library of validated instruments (EORTC, FACT-G, EQ-5D, SF-36, PROMIS); Professional Services manages scale licensing and validation; library size not published.

Source
About this support label

Validated instruments are available, with licensing and validation managed by Professional Services.

Supported

Pre-built, validated assessment libraries, the Rapid Start assessment catalog and an eCOA Science Services team with named scientists.

Source
About this support label

Validated libraries and science services are documented; managed licensing is not established.

Regulatory compliance and track record
Feature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Supported

Fully validated, 21 CFR Part 11 and GxP compliant platform used in 6,100+ trials; no regulatory approval counts published.

Source
About this support label

Part 11 and GxP compliance are stated; approval counts are not published.

Supported

States it has supported 70% of FDA and EMA new drug approvals since 2015 (company-wide, all endpoint types); ISO 27001:2022 and SOC 2 Type II are published separately.

Source
About this support label

ISO/SOC certifications are stated; this note does not establish a public certificate or audit report.

Global scale and languages
Feature definitions
Supported
Multicountry use or multilingual/localized participant support is documented.
Extended support
Both multicountry use and multilingual/localized participant support are documented.
Supported

80+ languages through translation services, 10+ pre-translated interface languages and 24/7 support.

Source
About this support label

Language support is documented; this note does not establish multicountry use.

Extended support

Studies in over 120 countries and over 100 languages; 25 years of DCT and hybrid trials.

Source
About this support label

The note reports studies across countries and languages.

Capture modes and integrations
Feature definitions
Supported
Electronic outcome capture and a connection to another trial system or device are documented.
Extended support
Capture on participant-owned and provisioned devices plus wearable or sensor integration are documented.
Supported

BYOD app, browser, SMS and messaging apps, site tablet mode and provisioned devices; integrates with major EDCs via REST API and webhooks. Wearable or sensor capture not documented.

Source
About this support label

App, web and EDC connections are documented; wearable or sensor capture is not.

Extended support

BYOD, web or provisioned devices, plus pre-validated connected devices (CGM, glucose meters, Opal motion sensors) integrated with the eCOA device.

Source
About this support label

BYOD and provisioned devices are offered with integrated, pre-validated connected devices.

Time to launch and self-service build
Feature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Extended support

Self-service and low-complexity eCOA builds go live in weeks; managed builds reach UAT in 4 to 8 weeks.

Source
About this support label

Self-service builds go live in weeks; managed builds reach UAT in four to eight weeks.

Supported

eCOA Swift deploys early-phase oncology trials in as little as 2 weeks and Rapid Start offers pre-configured assessments; builds are vendor-delivered, no self-service designer published.

Source
About this support label

Vendor-delivered oncology deployment timing is stated; a self-service designer is not documented.

Published pricing and terms
Feature definitions
Supported
A production pricing basis, model or contract terms beyond a sales contact are published.
Extended support
Numerical production prices or a free production option with its conditions are published.
Supported

Pricing process published: itemized, fixed-scope proposal with change-control terms within 5 business days, plus a Castor Essentials package for early-stage companies; no prices.

Source
Unknown

Not published: no price, pricing model or contract terms on the vendor site; pricing by sales contact only.

Source
About this support label

Sales contact alone does not establish a published pricing model, prices or contract terms.

Unknown does not mean unavailable. The public evidence does not establish support under this category’s definition.

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the eCOA guide using the same feature definitions.

More eCOA comparisons featuring one of these products.